Understanding Government has taken some time off from writing about how the Food and Drug Administration needs more money. But we’re back on the FDA/more cash beat today thanks to the Wall Street Journal’s Alicia Mundy.

Mundy reports on the efforts for broad agency reforms proposed by Sen. Charles Grassely (R-Ia.) and Rep. John Dingell (D-Mi.). More than just added money, the pair wants additional drug recall powers and, interestingly, to have the agency rein in "Madison Avenue" pharmaceutical company advertising.

While informative, Mundy’s piece inaccurately makes FDA reform sound like a crusade of these two maverick Congressman. In fact, there is fairly broad bipartisan agreement that the agency needs a serious boost.-MB

Comment RSS - You can skip to the end and leave a response. Pinging is currently not allowed.